B6E:FRA
Swedish Orphan Biovitrum AB (publ)
€41.44
arrow_upward
+0.78%(+0.32) 1D
Sep 4, 10:00:00 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for B6E...
Open
€41.44
High
€41.44
Low
€41.44
Mkt. cap
162.55B
Avg. vol.
15.00
Volume
0.00
52-wk high
€43.62
52-wk low
€24.28
No. of employees
2K
Open
€41.44
High
€41.44
Low
€41.44
Mkt. cap
162.55B
Avg. vol.
15.00
Volume
0.00
52-wk high
€43.62
52-wk low
€24.28
No. of employees
2K
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company dedicated to treatments in the areas of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA. Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world.
In 2025 it had a revenue of SEK 28.2 billion and around 1,900 employees. Wikipedia
About Swedish Orphan Biovitrum AB (publ)